The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of aspirin for stage III colorectal cancer: A randomized double-blind placebo-controlled trial (JCOG1503C, EPISODE-III trial).
 
Atsuo Takashima
Honoraria - Chugai Pharma; Lilly; Merck Serono; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
Research Funding - LSK BioPharma; Sumitomo Group; Takeda
 
Kenichi Miyamoto
No Relationships to Disclose
 
Yuya Sato
No Relationships to Disclose
 
Natsuko Okita
No Relationships to Disclose
 
Manabu Shiozawa
No Relationships to Disclose
 
Shigeki Yamaguchi
Speakers' Bureau - Chugai Pharma; Covidien; Johnson & Johnson; Lilly; Merck Serono; Taiho Pharmaceutical; TERUMO
 
Ryo Inada
No Relationships to Disclose
 
Yusuke Nishizawa
No Relationships to Disclose
 
Masayuki Ohue
Honoraria - Chugai Pharma; Taiho Pharmaceutical
Research Funding - Chugai Pharma (Inst); Taiho Pharmaceutical (Inst)
 
Nobuhiro Takiguchi
No Relationships to Disclose
 
Junki Mizusawa
No Relationships to Disclose
 
Hiroshi Katayama
Honoraria - Johnson & Johnson
 
Kenichi Nakamura
Honoraria - Eisai; Merck Serono; Nihonkayaku; Taiho Pharmaceutical
 
Taro Shibata
No Relationships to Disclose
 
Haruhiko Fukuda
Honoraria - Chugai Pharma; Taiho Pharmaceutical
 
Yasuhiro Shimada
Honoraria - AstraZeneca; Bayer Yakuhin; Chugai Pharma; Daiichi Sankyo; Lilly Japan; Merck Serono; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical; TAKEDA; Tsumura & Co.; Yakult Honsha
Research Funding - Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Lilly Japan (Inst); Merck Serono (Inst); MSD K.K (Inst); Taiho Pharmaceutical (Inst)
 
Yukihide Kanemitsu
No Relationships to Disclose
 
Tetsuya Hamaguchi
Honoraria - Bayer; Bristol-Myers Squibb Japan; Chugai Pharma; Lilly; Merck Serono; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
Consulting or Advisory Role - NanoCarrier
Research Funding - Chugai Pharma (Inst); Dainippon Sumitomo Pharma (Inst); Kobayashi Pharmaceutical (Inst); Merck Serono (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Yakult Honsha (Inst)